Recursion Pharmaceuticals, Inc.
RXRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001601830
In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Recursion Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 75 | 1 | 84 | +10 |
| Shares | 47.0M | 30 | 54.9M | +7.94M (+16.9%) |
| Value | $1.71B | $1.00K | $1.26B | −$451.1M (−26.3%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Recursion Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mitsubishi UFJ Trust & Banking Corp | 398,420 | $9.17M | 0.02% |
| Yong Rong (HK) Asset Management Ltd | 377,000 | $8.68M | 5.69% |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 259,941 | $5.98M | 0.19% |
| American Century Companies Inc | 151,359 | $3.48M | 0.00% |
| Rafferty Asset Management, LLC | 68,021 | $1.56M | 0.01% |
| Spouting Rock Asset Management, LLC | 52,851 | $1.22M | 0.61% |
| SG Americas Securities, LLC | 12,266 | $282.0K | 0.00% |
| Samson Rock Capital LLP | 10,278 | $237.0K | 0.15% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 7,826 | $180.0K | 0.00% |
| Signaturefd, LLC | 4,250 | $98.0K | 0.00% |
| Point72 Hong Kong Ltd | 2,987 | $69.0K | 0.01% |
| Nisa Investment Advisors, LLC | 2,777 | $64.0K | 0.00% |
| Cutler Group LP | 1,600 | $36.0K | 0.00% |
| Parallel Advisors, LLC | 400 | $9.00K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 208 | $5.00K | 0.00% |
| Activest Wealth Management | 186 | $4.00K | 0.00% |
| Wells Fargo & Company | 13 | $0 | 0.00% |
Sold out (7)
Institutions that held Recursion Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Bellevue Group AG | 20,000 | $730.0K |
| Caas Capital Management LP | 15,000 | $548.0K |
| Zimmer Partners, LP | 10,000 | $365.0K |
| Victory Capital Management Inc | 6,620 | $242.0K |
| Invesco Ltd. | 5,612 | $205.0K |
| ProShare Advisors LLC | 5,482 | $200.0K |
| Pinz Capital Management, LP | 1,240 | $45.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Recursion Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 30 | $1.00K |